The Asia Pacific Medical Device Reprocessing Market would witness market growth of 14.5% CAGR during the forecast period (2022-2028).
The term reprocessing is used specifically in several regulations (EU) 2017/745 (MDR) on medical devices when defining the conditions for the reprocessing and additional usage of single-use devices. The Regulation refers to the appropriate processes for enabling reuse, which include disinfection, cleaning, packaging, and, where relevant, the validated approach of re-sterilization appropriate to the Member State or the Member States, in which the instrument has been placed on the market when establishing requirements for reusable devices rather than using the term reprocessing expressly.
Unlike reusable devices, which can be used again after following the proper cleaning, disinfection, and sterilization protocols, single-use devices are designed by the manufacturer to be used just once. As a result, MDR defines several obligations and specifications for the reprocessing of both reusable and single-use devices. Reusable medical equipment gets dirty and contaminated with bacteria when used on patients. Reusable devices go through reprocessing, a thorough, multi-step process to cleanse and then disinfect or sterilize them, to eliminate any danger of infection from a contaminated device.
There is a rising prevalence of people with a sedentary lifestyle across regional countries. Obesity, diabetes, and cardiovascular illnesses are on the rise as a result of physical inactivity, increasing tobacco use, and poor diet and nutrition, which are all part of the modern lifestyle. One of the major risk factors of this type of lifestyle is chronic diseases. An inactive lifestyle can result in a number of chronic diseases. Moreover, most of these chronic illnesses are completely avoidable.
The China market dominated the Asia Pacific Medical Device Reprocessing Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $299.9 million by 2028. The Japan market is estimated to grow a CAGR of 13.8% during (2022 - 2028). Additionally, The India market would experience a CAGR of 15.3% during (2022 - 2028).
Based on Type, the market is segmented into Reprocessing Support & Services and Reprocessed Medical Devices. Based on Device Category, the market is segmented into Critical Devices, Semi- Critical Devices, and Non- Critical Devices. Based on Application, the market is segmented into Cardiology, Gynecology, General Surgery & Anesthesia, Gastroenterology, Arthroscopy & Orthopedic Surgery, and Others. Based on countries, the market is segmented into China, Japan, India, Australia, South Korea, Singapore, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Medical Device Reprocessing Market is Projected to reach USD 4 Billion by 2028, at a CAGR of 13.7%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Stryker Corporation, Johnson & Johnson, Medline Industries, Inc. (Centurion Medical Products Corporation), Medtronic PLC, Steris Healthcare, Arjo Group (ReNu Medical, Inc.), Cardinal Health, Inc. (Sustainable Technologies), Avante Health Solutions, Konoike Group, and Vanguard AG.
By Type
By Device Category
By Application
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
